These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18670236)

  • 1. HIV immune reconstitution syndrome in sub-Saharan Africa.
    Murdoch DM; Venter WD; Feldman C; Van Rie A
    AIDS; 2008 Aug; 22(13):1689-90. PubMed ID: 18670236
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV immune reconstitution syndrome in sub-Saharan Africa.
    Easterbrook PJ
    AIDS; 2008 Mar; 22(5):643-5. PubMed ID: 18317006
    [No Abstract]   [Full Text] [Related]  

  • 3. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review.
    Barth RE; van der Loeff MF; Schuurman R; Hoepelman AI; Wensing AM
    Lancet Infect Dis; 2010 Mar; 10(3):155-66. PubMed ID: 20185094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of antiretroviral therapy in sub-saharan Africa.
    Weller I
    Clin Infect Dis; 2006 Sep; 43(6):777-8. PubMed ID: 16912955
    [No Abstract]   [Full Text] [Related]  

  • 5. Kaposi's sarcoma in sub-Saharan Africa: a current perspective.
    Mosam A; Aboobaker J; Shaik F
    Curr Opin Infect Dis; 2010 Apr; 23(2):119-23. PubMed ID: 19996745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Meaning of "Rapid" Antiretroviral Therapy Initiation for Adolescents With Human Immunodeficiency Virus in Sub-Saharan Africa.
    Zanoni BC; Haberer JE
    J Infect Dis; 2020 Aug; 222(5):705-707. PubMed ID: 31682259
    [No Abstract]   [Full Text] [Related]  

  • 7. ChatGPT has the potential to enhance antiretroviral therapy adherence among adolescents with HIV in sub-Saharan Africa.
    Kizito S
    Med Educ Online; 2023 Dec; 28(1):2246781. PubMed ID: 37563880
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
    Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
    Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis associated immune reconstitution inflammatory syndrome.
    Sinha S; Sharma SK
    Indian J Tuberc; 2010 Oct; 57(4):177-9. PubMed ID: 21141335
    [No Abstract]   [Full Text] [Related]  

  • 10. Traditional health practitioners are key to scaling up comprehensive care for HIV/AIDS in sub-Saharan Africa.
    Homsy J; King R; Balaba D; Kabatesi D
    AIDS; 2004 Aug; 18(12):1723-5. PubMed ID: 15280784
    [No Abstract]   [Full Text] [Related]  

  • 11. Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival.
    Staehelin C; Rickenbach M; Low N; Egger M; Ledergerber B; Hirschel B; D'Acremont V; Battegay M; Wagels T; Bernasconi E; Kopp C; Furrer H;
    AIDS; 2003 Oct; 17(15):2237-44. PubMed ID: 14523281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low incidence of the immune reconstitution inflammatory syndrome among HIV-infected patients starting antiretroviral therapy in Gabon: a prospective cohort study.
    Janssen S; Osbak K; Holman R; Hermans S; Moekotte A; Knap M; Rossatanga E; Massinga-Loembe M; Alabi A; Adegnika A; Meenken C; van Vugt M; Kremsner PG; Meintjes G; van der Poll T; Grobusch MP
    Infection; 2017 Oct; 45(5):669-676. PubMed ID: 28349491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study.
    Murdoch DM; Venter WD; Feldman C; Van Rie A
    AIDS; 2008 Mar; 22(5):601-10. PubMed ID: 18317001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.
    van Zyl GU; Frenkel LM; Chung MH; Preiser W; Mellors JW; Nachega JB
    AIDS; 2014 Nov; 28(18):2643-8. PubMed ID: 25493592
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors for immune reconstitution inflammatory syndrome under combination antiretroviral therapy can be aetiology-specific.
    Espinosa E; Ormsby CE; Vega-Barrientos RS; Ruiz-Cruz M; Moreno-Coutiño G; Peña-Jiménez A; Peralta-Prado AB; Cantoral-Díaz M; Romero-Rodríguez DP; Reyes-Terán G
    Int J STD AIDS; 2010 Aug; 21(8):573-9. PubMed ID: 20975091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV/AIDS in 2004: the epidemiologist's point of view.
    Girardi E; Lauria FN; Ippolito G
    Cell Death Differ; 2005 Aug; 12 Suppl 1():837-44. PubMed ID: 15776000
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of appropriate treatment for people with comorbid HIV/AIDS and epilepsy in sub-Saharan Africa.
    Birbeck G; Chomba E; Ddumba E; Kauye F; Mielke J
    Epilepsia; 2007 Jul; 48(7):1424-5. PubMed ID: 17635568
    [No Abstract]   [Full Text] [Related]  

  • 18. Alcohol and antiretroviral adherence? What about Africa?
    Van geertruyden JP; Woelk G; Mukumbi H; Ryder R; Colebunders R
    J Acquir Immune Defic Syndr; 2010 Aug; 54(4):e10. PubMed ID: 20611030
    [No Abstract]   [Full Text] [Related]  

  • 19. Interventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy.
    Peterson K; van Griensven J; Huis in 't Veld D; Colebunders R
    Expert Rev Anti Infect Ther; 2012 Jan; 10(1):43-50. PubMed ID: 22149613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achieving HIV targets by 2030: the possibility of using debt relief funds for sustainable HIV treatment in sub-Saharan Africa.
    Abah RC
    J Public Health Policy; 2020 Dec; 41(4):421-435. PubMed ID: 32747703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.